Variable | Unadjusted effect | 95% CI | P-value | Adjusted effect* | 95% CI | P-value |
---|---|---|---|---|---|---|
Age | −0.24 | −0.52,0.05 | 0.11 | 0.09 | −0.18,0.36 | 0.52 |
Gender | 0.41 | −0.34,5.16 | 0.86 | −2.54 | −7.19,2.11 | 0.28 |
Marital status | −1.05 | −2.59,0.48 | 0.24 | −0.88 | −2.34,0.59 | 0.24 |
LogMar best eye | −25.58 | −33.02, −18.14 | < 0.001 | −10.40 | −19.04,-1.74 | 0.02 |
LogMar treated eye | −6.87 | −11.64,-2.10 | 0.005 | −4.47 | −8.99,0.06 | 0.05 |
EQ-5D score | 18.01 | 8.41,27.61 | < 0.001 | 7.98 | 0.68,15.27 | 0.03 |
NEI-VFQ 25 baseline | 0.80 | 0.71,0.90 | < 0.001 | 0.69 | 0.53,0.84 | < 0.001 |
Treatment intensity | 1.53 | −3.07,0.01 | 0.05 | −0.47 | −2.29,1.35 | 0.61 |
PASS 5 | −4.83 | −7.46,- 2.21 | < 0.001 | 0.15 | −2.24,2.55 | 0.89 |